Case report: Dichloroacetate-induced methaemoglobinaemia in a G6PD-deficient neonate (2024)

Peer-Reviewed Study · Tan ZL, Ng NBH, Ong JSM · October 27, 2024

Tan ZL et al., 2024-10-27: Case report of a G6PD-deficient neonate with dichloroacetate-induced methemoglobinemia in whom methylene blue was avoided because of oxidative risk and transfusion was used instead.

In this case, methylene blue, the standard treatment for methaemoglobinaemia, may result in further oxidative stress.

Tan ZL et al., 2024-10-27: Case report of a G6PD-deficient neonate with dichloroacetate-induced methemoglobinemia in whom methylene blue was avoided because of oxidative risk and transfusion was used instead. C3 (harm/limitation limb). Study type: single case report (Pediatr Blood Cancer 2025;72:e31408), N=1, 3 weeks old, Singapore (National University Hospital authors per journal listing; affiliation not printed in the abstract). Country of care: Singapore. Methylene blue was NOT given; transfusion reversed the methemoglobinemia. Funder/conflicts not stated in the PubMed record. Comparator: none. PARTLY SUPPORTS C3: an acquired case in which methylene blue was withheld for harm risk, not a case of its use. Study type: case report.